13-Jan-2026
Lifeward Secures $47 Million Strategic Investment with Oramed to Expand into Biotech and MedTech
Market Chameleon (Tue, 13-Jan 5:33 AM ET)
Lifeward Forms Strategic Partnership and Financing Deal with Oramed
TipRanks (Tue, 13-Jan 8:48 AM ET)
Globe Newswire (Tue, 13-Jan 8:00 AM ET)
Oramed and Lifeward Announce Strategic Transaction
PRNewswire (Tue, 13-Jan 7:58 AM ET)
Lifeward Appoints Bob Marshall as Chairman of the Board
Globe Newswire (Fri, 19-Dec 4:05 PM ET)
Globe Newswire (Wed, 17-Dec 8:00 AM ET)
Globe Newswire (Wed, 3-Dec 8:00 AM ET)
Globe Newswire (Mon, 17-Nov 8:00 AM ET)
Lifeward Ltd. Reports Third Quarter 2025 Financial Results
Globe Newswire (Fri, 14-Nov 8:00 AM ET)
Lifeward to Report Third Quarter Financial Results on November 14, 2025
Globe Newswire (Mon, 10-Nov 7:00 AM ET)
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Lifeward Ltd. - trades on the NASDAQ stock market under the symbol LFWD.
As of January 13, 2026, LFWD stock price climbed to $0.69 with 1,431,461 million shares trading.
LFWD has a beta of 0.98, meaning it tends to be less sensitive to market movements. LFWD has a correlation of 0.03 to the broad based SPY ETF.
LFWD has a market cap of $12.58 million. This is considered a Sub-Micro Cap stock.
Last quarter Lifeward Ltd. - reported $6 million in Revenue and -$.19 earnings per share. This fell short of revenue expectation by $-116,000 and missed earnings estimates by -$.03.
LFWD has underperformed the market in the last year with a return of -63.7%, while the SPY ETF gained +20.8%. In the last 3 month period, LFWD fell short of the market, returning -7.0%, while SPY returned +6.5%. However, in the most recent 2 weeks LFWD has outperformed the stock market by returning +13.2%, while SPY returned +0.9%.
LFWD support price is $.60 and resistance is $.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFWD shares will trade within this expected range on the day.